Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]-BLU-5937
Clinical trial NCT05244759 · COMPLETED
Trial details
- NCT number
- NCT05244759
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2020-09-23
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.